OBM Geriatrics is an Open Access journal published quarterly online by LIDSEN Publishing Inc. The journal takes the premise that innovative approaches – including gene therapy, cell therapy, and epigenetic modulation – will result in clinical interventions that alter the fundamental pathology and the clinical course of age-related human diseases. We will give strong preference to papers that emphasize an alteration (or a potential alteration) in the fundamental disease course of Alzheimer’s disease, vascular aging diseases, osteoarthritis, osteoporosis, skin aging, immune senescence, and other age-related diseases.
Geriatric medicine is now entering a unique point in history, where the focus will no longer be on palliative, ameliorative, or social aspects of care for age-related disease, but will be capable of stopping, preventing, and reversing major disease constellations that have heretofore been entirely resistant to interventions based on “small molecular” pharmacological approaches. With the changing emphasis from genetic to epigenetic understandings of pathology (including telomere biology), with the use of gene delivery systems (including viral delivery systems), and with the use of cell-based therapies (including stem cell therapies), a fatalistic view of age-related disease is no longer a reasonable clinical default nor an appropriate clinical research paradigm.
Precedence will be given to papers describing fundamental interventions, including interventions that affect cell senescence, patterns of gene expression, telomere biology, stem cell biology, and other innovative, 21st century interventions, especially if the focus is on clinical applications, ongoing clinical trials, or animal trials preparatory to phase 1 human clinical trials.
Papers must be clear and concise, but detailed data is strongly encouraged. The journal publishes research articles, reviews, communications and technical notes. There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 8 days from acceptance to publication (median values for papers published in this journal in 2020, 1-2 days of FREE language polishing time is also included in this period).
Research on Bone Diseases in Older Adults
Submission Deadline: June 30, 2022 (Open) Submit Now
Lecturer, Department of Health and Behavior Studies, Program in Health Education, Teachers College, Columbia University, New York, NY, USA.
Research Interests: Osteoporosis; osteoarthritis; knee osteoarthritis; falls prevention; depression; aging
About This Topic
Bone diseases, such as osteoporosis, Paget’s disease, bone cancer, and osteomalacia, are especially prevalent among the older population. Associated with varying degrees of bone thinning, fragility, and increased susceptibility to fracture, high rates of disability as well as pain, these health challenges often go overlooked or neglected in the absence of fractures or overt disability.
Unfortunately, those states are challenging to treat, especially if relatively little has been done over time to reduce the degree of bone destruction, or thinning, among other bone associated pathological changes. They are however, amenable to prevention, as well as treatment.
This Special Edition welcomes articles that focus on this topic of bone health and disease among older adults, especially from the viewpoint of prevention, as well as treatment, and early detection.
Articles of any genre concerning the importance of early detection, preventing and treating geriatric bone diseases such as osteoporosis and its correlates, outcomes of bone diseases, such as fractures, age changes in bone, and poor bone health and bone pain due to steroid usage, rheumatoid arthritis, obesity, osteoarthritis, poor nutrition, and radiation, among other factors heightening bone damage in older adults are specifically sought.
Bone Mass, Bone Loss, Bone Pain, Cancer, Fracture, Osteomalacia, Osteoporosis
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.